Skip to main content

Table 2 Biochemical and hormonal parameters

From: Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels

Variable (mean ± SD)

PCOS

(n = 46)

PCOS+HT (n = 46)

P value

TSH, μIU/mL

1.8 ± 0.9

2.7 ± 2.1

0.569

Free T3, pg/mL

3.2 ± 0.6

3.4 ± 0.7

0.247

Free T4, ng/dl

0.9 ± 0.3

1 ± 0.8

0.369

Anti-TPO, IU/mL

2.5 ± 2.7

248.3 ± 306.7

< 0.001

Anti-TG, IU/mL

1.03 ± 1.16

36.4 ± 62.3

< 0.001

Glucose, mg/dl

93.8 ± 20.1

95.1 ± 33.5

0.819

Fasting insulin, μIU/mL

24.3 ± 39.9

23.1 ± 31.7

0.877

Hemoglobin, g/dL

12.5 ± 1.04

12.2 ± 1.4

0.249

Hematocrit

38.03 ± 4.3

37.06 ± 3.8

0.259

FSH, mIU/mL

6.2 ± 1.7

6.8 ± 4.8

0.424

LH, mIU/mL

11.1 ± 7.1

7.5 ± 5.5

0.007

Estradiol, pg/mL

61.1 ± 33.9

57.2 ± 36.8

0.601

Progesteron, ng/mL

0.9 ± 0.8

0.7 ± 0.3

0.125

DHEA-S, μg/dl

342.5 ± 130.9

306.6 ± 141.5

0.211

17-OH Progesteron, ng/ml

2.05 ± 1.82

1.73 ± 1.01

0.308

Testosteron, ng/mL

0.8 ± 0.5

0.9 ± 0.5

0.44

Prolaktin, ng/mL

12.4 ± 6.6

11.02 ± 5.4

0.273

SHBG, nmol/L

26.9 ± 17.3

37.9 ± 34.7

0.058

Androstenedion, ng/mL

4.1 ± 2.5

4.3 ± 3.7

0.783

Vitamin D, ng/mL

14.7 ± 6.9

16.5 ± 12.6

0.413

HOMA-IR

5.3 ± 9.2

4.6 ± 6.6

0.67

Cholesterol, mg/dL

173.8 ± 33.5

177.2 ± 37.9

0.649

HDL-C, mg/dL

46.04 ± 9.7

47.4 ± 12.01

0.537

LDL-C, mg/dL

102.7 ± 28.8

106.4 ± 36.1

0.587

Triglyceride, mg/dL

131.01 ± 70.3

125.8 ± 83.7

0.749

Calsiyum, mg/dL

9.1 ± 0.4

9.2 ± 0.5

0.574

Phosphorus, mg/dL

3.1 ± 0.7

3.1 ± 0.8

0.759

Ovary Volume, mm3

 Right ovary

11.4 ± 3.8

10.08 ± 4.5

0.654

 Left ovary

11.3 ± 4.9

10.3 ± 6.2

0.985

Antral Follicle Count (AFC), N

 Right ovary

14.2 ± 4.2

8.3 ± 4.6

0.034

 Left ovary

14.8 ± 5.3

8.2 ± 4.1

0.012

AMH, ng/mL

12.4 ± 8.1

8.8 ± 8.8

0.043

  1. SD Standard deviation, PCOS Polycystic ovary syndrome, HT Hashimoto’s Thyroiditis, TSH Thyroid-stimulating hormone, Anti-TG Anti-thyroglobulin, Anti-TPO Anti-thyroid peroxidase, HOMA-IR Homeostasis model assessment insulin resistance index, HDL-C Highdensity lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, SHBG sex hormone binding globulin, DHEAs dehydroepiandrosterones, AMH Anti-Müllerian hormone, FSH Follicle-stimulating hormone